K3I grants 172,000 stock options at exercise price 5,135 won (above current price 4,010 won) – limited dilution risk

K3I announced a correction to its stock option grant, reducing the number of grantees from 65 to 61 and shares from 178,500 to 172,000 due to resignations. The board resolved on December 27, 2024.
The exercise price is set at 5,135 won, slightly below the grant date closing price of 5,230 won but significantly above the current market price of 4,010 won. Thus, the options are currently out-of-the-money, posing limited immediate dilution risk.
Total outstanding stock options after this grant increase to 366,452 shares, representing approximately 4.9% of total issued shares. However, since exercise requires a stock price increase, dilution impact on existing shareholders is near-term limited.
Key recipients include registered director Seo Heung-deok (40,000 shares) and unregistered director Park Young-seop (10,000 shares), with 122,000 shares allocated to 58 employees.
[AI Analysis]This disclosure reflects a routine long-term incentive for management and employees, with minimal short-term impact on shareholder value. However, the low intrinsic value due to the current stock price below the exercise price warrants attention. Potential dilution upon future stock price appreciation should be monitored.